INSOMNIA
https://doi.org/10.21518/2079-701X-2017-0-52-58
Abstract
The article tells about the current understanding and classification of insomnia, the diagnostic criteria and pathophysiology of the disorder. Different pharmacological groups of drugs used in the treatment of insomnia are discussed.
About the Authors
K. N. StryginRussian Federation
PhD in medicine
M. G. Poluektov
Russian Federation
PhD in medicine
References
1. American Academy of Sleep Medicine. International classification of sleep disorders, 3 nd ed.: Diagnostic and coding manual. Westchester, Ill.: American Academy of Sleep Medicine, 2014.
2. Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K. The neurobiology, investigation, and treatment of chronic Insomnia. Lancet Neurol, 2015, 14: 547-58.
3. Michael ML. Etiology and Pathophysiology of Insomnia. (In Principles and practice of sleep medicine. Kryger M, Roth T, Dement WC, eds.). Elsevier, Inc.: Philadelphia, 2016: 769-784.
4. Krystal AD. Pharmacologic Treatment of Insomnia: Other Medications. (In Principles and practice of sleep medicine. Kryger M, Roth T, Dement WC, eds.). Elsevier, Inc.: Philadelphia, 2016: 842-846.
5. Ковальзон В.М., Стрыгин К.Н. Нейрохимические механизмы регуляции сна и бодрствования: роль блокаторов гистаминовых рецепторов в лечении инсомнии. Эффективная фармакотерапия. Неврология и психиатрия. Спецвыпуск «Сон и его расстройства», 2013, 12: 8-15.
6. Schadeck SB, Chelly M et al. Comparative efficacy of doxylamine and zolpidem for the treatment of common insomnia. Sep Hop Paris, 1996, 72(13-14): 428-439.
7. Левин Я.И. Мелатонин в неврологической практике. Consilium Medicum, 2012, 2: 111-115.
Review
For citations:
Strygin KN, Poluektov MG. INSOMNIA. Meditsinskiy sovet = Medical Council. 2017;(1S):52-58. (In Russ.) https://doi.org/10.21518/2079-701X-2017-0-52-58